An examination of correlates of simultaneous opioid and benzodiazepine use among patients in medication treatment for opioid use disorder in a small midwestern community
- PMID: 35285423
- PMCID: PMC9969715
- DOI: 10.1080/10550887.2022.2042152
An examination of correlates of simultaneous opioid and benzodiazepine use among patients in medication treatment for opioid use disorder in a small midwestern community
Abstract
Background: Concurrent and/or simultaneous use of opioids and benzodiazepines has been associated with increased risk of accident and injury, as well as with co-occurring psychopathology. Objectives: The purpose of the present study was to explore potential correlates of simultaneous opioid and benzodiazepine use in a small community, including perceived risk, positive screens for psychiatric symptoms, and opioid-related consequences. Methods: A sample of 267 participants were recruited from a medication treatment provider that serves a small Midwestern community. Multinomial logistic regression was used to explore demographic and mental health correlates associated with self-reports of past-year simultaneous use. Zero-inflated Poisson regression was used to explore past-year consequences associated with reported simultaneous benzodiazepine and opioid use. Results: Intentional simultaneous use of opioids and benzodiazepines was associated with greater anxiety and depression symptoms, greater likelihood of a positive PTSD screen, and low self-perceived risk of simultaneous use. Individuals reporting opioid/benzodiazepine simultaneous use were also more likely to report opioid-related consequences. Conclusions: Results highlight the importance of assessing and treating simultaneous opioid/benzodiazepine co-use, as well as relevant comorbidities.
Keywords: Opioids; PTSD; anxiety; benzodiazepines; depression.
Conflict of interest statement
Disclosure Statement: The authors declare no conflicts of interest.
Similar articles
-
Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.Drug Alcohol Depend. 2013 Oct 1;132(3):580-6. doi: 10.1016/j.drugalcdep.2013.04.006. Epub 2013 May 18. Drug Alcohol Depend. 2013. PMID: 23688843 Free PMC article.
-
Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.Int J Drug Policy. 2019 May;67:52-57. doi: 10.1016/j.drugpo.2019.01.021. Epub 2019 Mar 18. Int J Drug Policy. 2019. PMID: 30897373 Free PMC article.
-
Prescribing of benzodiazepines and opioids to individuals with substance use disorders.Drug Alcohol Depend. 2017 Sep 1;178:223-230. doi: 10.1016/j.drugalcdep.2017.05.014. Epub 2017 Jun 20. Drug Alcohol Depend. 2017. PMID: 28666181
-
Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically.Drug Alcohol Depend. 2018 Feb 1;183:73-77. doi: 10.1016/j.drugalcdep.2017.10.023. Epub 2017 Dec 7. Drug Alcohol Depend. 2018. PMID: 29241103 Free PMC article.
-
Concurrent Opioid and Benzodiazepine Utilization Patterns and Predictors Among Community-Dwelling Adults in the United States.Psychiatr Serv. 2020 Oct 1;71(10):1011-1019. doi: 10.1176/appi.ps.201900446. Epub 2020 Jun 10. Psychiatr Serv. 2020. PMID: 32517642
Cited by
-
Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder.Front Psychiatry. 2023 Jan 19;14:1103739. doi: 10.3389/fpsyt.2023.1103739. eCollection 2023. Front Psychiatry. 2023. PMID: 36741122 Free PMC article.
-
Using Latent Class Analysis to Examine Polysubstance Use Patterns in Adolescents Aged 10-18: A Systematic Review.Addict Behav. 2025 May;164:108281. doi: 10.1016/j.addbeh.2025.108281. Epub 2025 Feb 6. Addict Behav. 2025. PMID: 39954664
References
-
- Earleywine M, Newcomb MD. Concurrent versus simultaneous polydrug use: Prevalence, correlates, discriminant validity, and prospective effects on health outcomes. Exp Clin Psychopharmacol. 1997;5(4):353–364. - PubMed
-
- Substance Abuse and Mental Health Services Administration (SAMHSA): Treating Concurrent Substance Use Among Adults. SAMHSA Publication No. PEP21-06-02-002. Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration, 2021.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous